Topics
Sector
Geography
Subject

Videos Library

All Videos

1424
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts

The NextLevel LifeSciences Videos Library is the full collection of video recordings (and supporting documentation) from all NextLevel LifeSciences events.

Latest Videos

Presentation

One region – one cohort: pooling Nordic data to achieve market access

Related topics: Pharmaceutical/Biotech, Nordic, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker

Thomas Fast
Project Manager & RWE Expert
Institute of Applied Economics & Health Research (ApHER)

Presentation

Workshop Overview - What you will learn

Related topics:
Availability: FREE
  • Target Audience
  • Why this course?
  • Why is sales a life skill?
  • Course Outcomes
  • What will you achieve?

 

Speakers

Geoff Cable                               
CEO & co-Founder                         
NextLevel Life Sciences

Luke Rogers
CEO & co-Founder
NextLevel Life Sciences

Presentation

Product Claim Management – An integral approach to systematically build clinical and economical product value.

Related topics: MedTech, Commercial, Regulations & Ethics
Availability: FREE
  • Beyond Marketing: Getting to the right product claims and getting the product claims right.
  • Beyond MDR: How to turn novel regulatory requirements into differentiating opportunities?
  • Beyond Product Launch: Clinical vs. economic claims? The right choices for effective Market Access. 
Speaker

Claus Schaffrath
Managing Director, MD squared
Consultant, Cetas Healthcare
The Netherlands

Presentation

The Future of Learning and Enablement in Med Device: Continuous, Adaptive, Personalised

Related topics: MedTech, Commercial, Digital & Technology, Capabilities & Effectiveness
Availability: FREE

Industry consolidation, competition and product innovation are driving the medical device industry to constantly evolve if they are to keep up with market and patient needs.  This poses a great challenge, but also a great opportunity, to learning and enablement leaders who strive to successfully support sales, medical affairs and distribution partners to develop strong customer relationships and deliver the best technology solutions for the end patient or consumer. In this talk, you will learn:

  • How learning leaders are driving behaviour change that improves job performance
  • New ways to scale and measure the impact of enablement initiatives on commercial goals
  • Case studies of how medical device providers and other leading enterprises are achieving commercial agility
  • How to apply best practice microlearning to commercial, medical affairs and channel enablement
Speaker

Michael Connolly
Enterprise Account Director, EMEA
Qstream, UK

Presentation

Impactful customer engagement: How to demonstrate ROI on your digital investments

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Experience how the first movers in medtech have proven digital technology ROI
  • See how you can use your digital investments to enable better customer experiences for payers and HCPs
  • Explore how digital technology supports a key account strategy
  • Learn how to get it right: start small and scale fast
  • Get C-level backing by showing measurable results
Speaker

Luis Rodriguez
Global Client Director
Agnitio, Denmark

Presentation

Integrated Health Solutions for Hospitals: Where to Play and How to Win?

Related topics: MedTech, Commercial, Capabilities & Effectiveness
Availability: FREE
  • Overview of ‘Solutions’ offerings
  • Performance of integrated health solutions so far
  • Industry-wide learnings and future trends
  • Common Pit-falls and Challenges
  • Overcoming the challenges in implementing ‘solutions’ strategy
Speakers

Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands

Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, USA

Presentation

Bringing meaningful metrics to the new medical affairs model

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
Speakers

Ian Greenway
Medical Affairs Director
Complete HealthVizion, UK

Charlotte Moseley
Global Head
Complete HealthVizion, UK

Presentation

Building Effective Medical Teams: Internal Vs External Approaches

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker

Gavin Kenny
Account Director
OPEN Health Medical Communications, UK

Presentation

How can patient-centred outcomes enhance your evidence strategy?

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
Speaker

Angela Rylands
Principal Consultant Patient Centred Outcomes
Open Health, UK

Presentation

Biopharmaceutical Acceleration Model for product development and commercialization

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Historically, product development has largely been disengaged from commercialization
  • However, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • This presentation will describe and illustrate with a case study the benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs
Speaker

Erwin De Cock
Principal, Real-World & Late Phase
Syneos Health

Presentation

Actionable approaches to driving Medical Affairs effectiveness

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
  • Decision-making to create simplicity
  • Implementation of strategic frameworks
  • Organizational culture and performance in Medical Affairs
Speaker

Gemma Pfister
Executive
Vynamic, UK

Presentation

Increasing the efficiency of your Medical Affairs Team: The Silent Time Killer of Copy Review

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE

Case Study: How outsourcing can unburden your team to focus on value-adding relationships

Speaker

Tessa Pugh
Director
PharmaReview, UK

Presentation

Leveraging online discussion platforms for optimal stakeholder engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement 
  • Learn about innovative communication solutions that leading organizations utilize to overcome these challenges 
  • Discuss how to use these solutions to deliver improved engagement outcomes while maintaining regulatory compliance
Speaker

Peter Gannon
Senior Vice President, Business Partnerships
Within3

Presentation

Measuring the return from pharmaceutical innovation 2018

Related topics: Discovery & R&D Innovation, Digital & Technology
Availability: FREE

The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. However, there are opportunities to reverse this trend, which will require new ways of working and a complete digital transformation to unlock R&D productivity and deliver the next generation of scientific breakthroughs.

Speaker

Mark Steedman
Research Manager
Deloitte UK Centre for Health Solutions

Presentation

Extreme-Scale Cloud-Based Infrastructure needed for global genomic data

Related topics: IT & Big Data
Availability: FREE
  • Cloud genomic data sets are approaching a total of 250 Petabytes representing an unprecedented resource for research and clinical applications
  • Extreme-scale cloud-based compute and tools are required to federate and utilize the emerging global resource, conforming to localized compliance requirements
  • A rapid evolution in data resource architecture and applicable tools is required, with an important role to be played by Artificial Intelligence
Speaker

Richard Daly
CEO
DNAnexus, Inc., USA

Presentation

Bridging the gap: Translating expedited regulatory approval into optimal reimbursement

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Regulations & Ethics
Availability: FREE
Regulatory approval has traditionally been the main hurdle for developers trying to bring needed new drugs to patients. However, today, expedited regulatory pathways enable drugs for severe diseases to receive approval with less data whilst payers, in the face of budgetary pressures, are demanding more data. Thus, the gap has widened between what evidence regulators require and what payers desire.
 
Strategies to bridge this gap and translate regulatory approval into optimal reimbursement are becoming increasingly key to ensure the commercial success of innovative new products, which will be the focus of this presentation and will include:
- Making RCTs more payer relevant.
- Real world evidence utilization.
- Innovative pricing models.
- Early scientific advice.
Speakers

Janice Haigh
VP Pricing & Market Access
Parexel Access Consulting

Richard Macaulay
Principal Consultant
Parexel

Presentation

Market access & go-to-market strategy for transformative therapies: Changing our mindset

Related topics: Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE
  • The key go-to-market opportunities and challenges for autologous gene and cell therapies - from the regulatory (‘benefit/risk’), market access (funding and pricing) and commercialisation (treatment delivery) perspectives
  • The value of integrated, cross-functional decision-making, strategies and tactics to overcome go-to-market hurdles for autologous gene and cell therapies
  • The implications for Pharma around organisational structure, organisational processes and capabilities
Speaker

Akshay Kumar
Principal Consultant
Huron Consulting Group, UK

Presentation

From PMPRB reforms to pCPA to National Pharmacare? Where is Canada heading when it comes to pricing and reimbursement of pharmaceuticals?

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Canada
Availability: FREE
  • Impact of PMPRB proposed price reforms – new reference countries, HTA to set price thresholds, risk based assessments.
  • pan Canadian Pharmaceutical Alliance (pCPA) – more structure, guidelines, for negotiating public payer listing agreements / access schemes.
  • Implementation of National Pharmacare –  proposals for “public only” national pharmacare program are again being considered seriously by Federal advisory committee.
  • Insurers for private drug plans seek to maintain market but gain access to pCPA rebates.
  • Outlook and implications for Canadian pricing and market access.
Speaker

Dylan Lamb-Palmer
Manager, Pricing and Data Analytics
PDCI Market Access, Canada

Presentation

What it worth to you? Assessing value of product attributes through decision-analytic modeling

Related topics: Pharmaceutical/Biotech, Market Access & HEOR
Availability: FREE
  • How a product's characteristics or attributes contribute to both individual willingness to pay and "value" from different perspectives (e.g., stakeholder, society).
  • The various methodologies through which attribute value can be assessed.
  • A real-world case study of how decision-analytic modeling helped a leading company establish the value of a unique product attribute, and by so doing justify higher tender pricing in a key EU market.
Speaker

Mason Russell
Vice President, Strategic Consulting (Life Sciences)
IBM Watson Health , USA

Presentation

Enabling value selling for Surgical & Implantable Devices

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • What is the role of market access in economic selling?
  • The challenge of quantifying value.
  • Building effective tools and training methods.
  • Partnering with commercial teams.
  • Case studies: Selling value in the UK and Germany.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Triggering incremental funding for medical innovations

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Are traditional reimbursement systems adequate for innovation?
  • Rewarding value, not only cost or evidence
  • Innovative Payment Mechanisms in Europe
  • Implications to Market Access Strategy
Speaker

Ben Modley
Director of European Operations
ValueConnected

Presentation

Translating market needs into actual value stories

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Identifying decision-makers’ needs
  • Assessing the relevant data to support claims
  • Building a concrete value story
  • Next steps: Teams, not tools, demonstrate value
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Designing evidence strategies for successful EU launches

Related topics: MedTech, Market Access & HEOR
Availability: FREE

The progression towards a pan-European HTA framework will pose new challenges to device and diagnostics companies as they contend with a heightened focus on higher quality evidence, with unchanged local decisionmaking around reimbursement.  This session will explore concepts in evidence development for medical technologies, and how European payment systems have evolved to demand greater clinical and economic value than ever before.  

Speaker

Stephen Hull
Principal and Founder
Hull Associates, USA

Presentation

Med Tech companies transform from “suppliers” to “partners”. What’s next? Opportunities for new sources of value

Related topics: MedTech, Market Access & HEOR
Availability: FREE
  • Technology disruption: Non-healthcare players entering the market. Impact on our business model?
  • Technology-enabled care delivery: How do data, analytics and machine learning offer opportunities to address emerging payer and provider needs?
  • Reimaging the future state of med tech innovation: What kind of capabilities do we need to capture these new sources of value?
  • The case of diabetes management: Data at the center.
Speaker

Sotiris Rompas
Director, Life Sciences
Huron Consulting, UK

Presentation

“Value communication during pathway disruption” : The opportunity and challenge of disruptive medicine including CAR-T & Gene Therapy

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Defining pathway disruption
  • Challenges of value measurement
  • Market Access and Real World Evidence solutions to overcome challenges
Speaker

Amanda Pulfer
Managing Director
PH Associates

Presentation

Real World Evidence Opportunities in Medical Affairs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Areas of opportunity
  • Main hurdles
  • Elegant method to answer new questions with existing data
  • Methodology – bias and confounding
  • Opportunity for strategic partnership
  • Value for money
Speaker

Torkild Stenbock
General Manager
LINK Medical Research, Norway

Presentation

Patient Centricity in Non-Interventional Real-world Evidence Study Programs

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Patient-Centricity & Care
Availability: FREE
  • Existing data sources as unique tools for study program pre-evaluation
  • Unique patient centric methodology to answer new questions
  • Patient centric, active surveillance methodology as a tool for in-depth validation of special medial outcome events
  • Classical non-interventional study approaches to complement the holistic view on the patient
Speaker

Marc Pignot
Director Real World Research Consulting
Kantar Health, Germany

Presentation

Biopharmaceutical Acceleration Model for Product Development & Commercialization

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, Clinical
Availability: FREE
  • Outlining how, historically, product development has largely been disengaged from commercialization
  • Exploring how, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • Describing and  illustrating with a case study the  benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization,  involving comprehensive evidence development to meet clinical, regulatory and commercial needs
Speaker

Erwin De Cock
Principal, Real-World & Late Phase
Syneos Health

Presentation

A cigar is just a cigar...or is it?: Turbocharging MSL Communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology, Medical Science Liaison
Availability: FREE

Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.

Speaker

Pamela Peters
Szenior Director, Medical Affairs Strategic Solutions
Medscape

Presentation

The value of digital communications in medical affairs – practical and compliance considerations

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE
Speaker

Gemma Allen
Senior Digital Communications Lead
Succinct Medical Communications

Presentation

Metrics to meaning: Measuring the success of medical communications in a digital airspace

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology, Capabilities & Effectiveness
Availability: FREE
  • The importance of metrics to demonstrate value and impact of communication programmes
  • From reach and engagement to behavioural metrics
  • Practical approaches to implementing metrics
Speakers

Robert Poole
Director of Scientific Services
Complete HealthVizion

Stephen Allison
Business Development Director
Complete HealthVizion, UK

Presentation

Leveraging Online Discussion Platforms for Optimal Stakeholder Engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement
  • Learn about innovative communication solutions that leading organizations are utilizing to overcome these challenges
  • Discuss the use of these solutions in delivering improved engagement outcomes, while remaining regulatory compliant
Speaker

Lance Hill
CEO
Within3

Presentation

Systematic Value Generation and Claim Prioritization based on Economic Impact

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Discover the relevant claim space for your target customer
  • Assess value and regulatory implications for aspired economic claims
  • Building a claim portfolio on differentiating impact before and after product launch
Speakers

Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands

Claus Schaffrath
Managing Director, MD squared
Consultant, Cetas Healthcare
The Netherlands

Presentation

The best buyer experience wins - How to use digital to leave a mark with the empowered buyer?

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Empowered buyer teams force Marketing & Sales to step up their game.
  • Marketing can support sales teams to become more solution-centric.
  • Sales teams can go beyond the expected and impact the modern-day buyer.
  • Ceterix, bioMérieux and ARGEN use sales enablement technology to step change Marketing and Sales alignment and grow sales productivity.
Speaker

Ellen Atkinson
Account Executive
Showpad

Presentation

Value-Based Procurement: differentiating with Value

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Moving the perspective from price to cost
  • Quantifying value in procurement
  • Case example: from lower cost to best option
  • Moving forward: role of the industry
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Customer-Centric Business Models: Where to start and How to Deliver?

Related topics: MedTech, Commercial
Availability: FREE
A perspective of the customer insight specialists on developing customer-centric business models
Key areas:
  • Role of Customer Insights in developing customer-centric business models
  • What are the different ways of approaching customer-centric pain points and unmet needs
  • How to distill impactful customer needs from customer wishlist
  • How to develop and validate business models through customer insights 
Speakers

Dushyant Gupta
Senior Client Engagement Director
Cetas Healthcare Insights, USA

Sumit Mehta
Managing Director
Cetas Healthcare Insights, Netherlands

Presentation

Med Tech companies transform from “suppliers” to “partners”. What’s next? Opportunities for new sources of value

Related topics: MedTech, Market Access & HEOR, Commercial
Availability: FREE
  • Technology disruption: Non-healthcare players entering the market. Impact on our business model?
  • Technology-enabled care delivery: How do data, analytics and machine learning offer opportunities to address emerging payer and provider needs?
  • Reimaging the future state of med tech innovation: What kind of capabilities do we need to capture these new sources of value?
  • The case of diabetes management: Data at the center.
Speaker

Sotiris Rompas
Director, Life Sciences
Huron Consulting, USA

Presentation

Get the backing from the C-Suite: how to demonstrate ROI on your digital investments

Related topics: MedTech, Commercial, Digital & Technology
Availability: FREE
  • Understand how to turn the C-Suite into digital advocates 
  • Experience how the first movers in medtech have proven digital technology ROI
  • See how you can use your digital investments to enable better customer experiences for payers and HCPs
  • Explore how digital technology supports a key account strategy
  • Learn how to get it right: start small and scale fast 
Speaker

Lars Meincke
Chief Commercial Officer
Agnitio, Denmark

Presentation

Data and strategic perspective

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research, IT & Big Data
Availability: FREE
Speaker

Anthony Page
CEO
Voxx Analytics

Presentation

A cigar is just a cigar...or is it?: Turbocharging MSL Communications

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE

Misunderstanding a simple comment—we’ve all been there. It happens because each of us brings our unique biases and baseline understandings to the table and we interpret what we hear through those biases and baselines. You can increase the chances that your message will be understood accurately by, first, understanding where your listener is coming from. This session will share data and insights regarding MSL training and about some of the beliefs and biases of MSLs and the physicians with whom they communicate.

Speaker

Pamela Peters
Senior Director, Medical Affairs Strategic Solutions
Medscape

Presentation

Futureproofing the Medical Affairs function in your organization

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Capabilities & Effectiveness
Availability: FREE
Speaker

William Soliman
President & CEO
Accreditation Council for Medical Affairs 

Presentation

Medical Affairs holds the reins in quality based medicine

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Digital & Technology
Availability: FREE

No longer is the patient expected to be a silent bystander in the healthcare process. Increasingly, the patient stands at center stage, surrounded by healthcare providers, payers, educators, and other players.  This new patient-centricity—so crucial to quality healthcare—elevates the role of COMMUNICATION in the pharmaceutical industry. COMMUNICATION—between physician and patient, between pharmaceutical company and physician, between pharma and external regulators, and more —  and, as the hub of all that COMMUNICATION, Medical Affairs holds the reins to success, providing added-value to both internal and external stakeholders . This session will examine the factors that foster effective COMMUNICATION, both externally and internally,  and will provide data-driven case-based insights and examples.

Speaker

Pamela Peters
Senior Director, Medical Affairs Strategic Solutions
Medscape

Presentation

Leveraging online discussion platforms for optimal stakeholder engagement

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement
Availability: FREE
  • Identify the logistical and resource barriers to domestic and global stakeholder engagement
  • Learn about innovative communication solutions that leading organizations are utilizing to overcome these challenges
  • Discuss the use of these solutions in delivering improved engagement outcomes, while remaining regulatory compliant
Speakers

Michael Kirby
Vice President, Business Partnerships,
Within3

Robert Honigberg
Sr. Medical Director, Medical Affairs
Flexion Therapeutics

Presentation

How to achieve effective medical communication and also optimize field force: A Revolutionary Approach for KOL mapping

Related topics: Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Medical Science Liaison
Availability: FREE
  • Circulate medical messaging from KOLs among the KOL network during pre-launch to ensure it percolates to the next tier including community opinion leaders (COLs) and local healthcare practitioners (HCPs)
  • Gain an overview of the “Pyramid of Influence” concept that increases participants’ understanding of how information flows among HCPs from all tiers, and how pharma can leverage this information to achieve a successful product launch
  • Learn how this concept helps medical and commercial teams work together prior to launch, not only to achieve effective medical communications but also to later optimize the field sales force
Speaker

Badal Shah
Managing Director, Health Analytics
QPHARMA

Presentation

The economic impact of value on different payment models

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Overview of main payment mechanisms
  • Basics of hospital financing
  • Activity-based payments: DRG
  • Value-based payments
  • Shift to value: is it happening now?
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Value-Based Reimbursement: including a new procedure in the Brazilian Public Healthcare System (SUS)

Related topics: MedTech, Market Access & HEOR, Latin America
Availability: FREE
  • Quantification of the unmet need for SUS.
  • Development of cost-effectiveness and budget impact analyses.
  • Potential scenarios for SUS with inclusion of technology.
  • Project results and next steps.
Speaker

Ernesto M. Nogueira
Managing Director
ValueConnected

Presentation

Access & Value of healthcare innovation in Latin America

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Latin America
Availability: FREE
  • Evolution of cost-containment tools in Latin America: reference pricing, health technology assessment and harnessing competition through procurement

  • Rise of health technology assessment as a decision-making tool in Latin America and implications for manufacturers looking to demonstrate the value of their innovation

  • Designing successful market access strategies that meet growing payer expectations 

Speakers

Miguel Martin de Bustamante
Principal
CBPartners, USA
 

Valeria Boers Trilles
Manager
CBPartners, USA

Presentation

Changing Trends in Real World Evidence

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Real-World Evidence & Late-Phase Research
Availability: FREE
  • Payer expectations.
  • The regulatory landscape.
  • Access to data.
  • The Increasing voice of the patient.
  • What is in store for sponsor-CRO partnerships?
Speaker

Noolie Gregory
Exec Dir, Client Engagement
Syneos Health, UK

Presentation

Early Access Programs – as a valuable component of market access and launch strategy

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, Clinical
Availability: FREE
  • Understand how these programs have been used extensively by pharma companies to address unmet medical need, but have broader market access benefits including another source of real world data.  This session will help people understand the basics about EAPs, the current landscape and industry trends around EAPs, and the types of data that various companies are capturing.  A case study will be provided.
Speaker

Kieron Lewis
Global Business Development Director
Clinigen, UK

Presentation

Facilitating innovative pricing, value based reimbursement and personalised medicine using revolutionary blockchain technology

Related topics: Pharmaceutical/Biotech, Market Access & HEOR, IT & Big Data
Availability: FREE
  • A new paradigm: Introduction to blockchain technology and its applications in healthcare
  • Digipharm: overcoming barriers to innovative pricing solutions and value based reimbursement
  • Innovative evidence generation and the impact on pricing & reimbursement
Speaker

Ahmed Abdulla
CEO
Digipharm, Switzerland

Register to view both free videos and browse premium content (and event documentation).

1424
videos of thought-leading presentations and interactive panel discussions from life science industry visionaries and experts
300+
new videos added every year!